Climb Bio Correlations

CLYM Stock

1.51 0.05 3.42%

The current 90-days correlation between Climb Bio and Caribou Biosciences is 0.48 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Climb Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Climb Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Climb Bio Correlation With Market

Weak diversification

The correlation between Climb Bio and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Climb Bio and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Climb Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.

Moving together with Climb Stock

0.63

JNJ

Johnson Johnson

Pair Corr

Moving against Climb Stock

0.52	BCH	Banco De Chile	Pair Corr
0.42	TRV	The Travelers Companies	Pair Corr
0.32	PG	Procter Gamble	Pair Corr

Related Correlations Analysis

	CRBU	CRSP	VERV	BEAM	PRME	SANA
CRBU		0.92	0.82	0.43	0.85	0.97	CRBU
CRSP	0.92		0.88	0.61	0.95	0.94	CRSP
VERV	0.82	0.88		0.4	0.84	0.81	VERV
BEAM	0.43	0.61	0.4		0.7	0.51	BEAM
PRME	0.85	0.95	0.84	0.7		0.9	PRME
SANA	0.97	0.94	0.81	0.51	0.9		SANA
	CRBU	CRSP	VERV	BEAM	PRME	SANA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Climb Stock performing well and Climb Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Climb Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CRBU	5.41	1.36	0.24	0.77	4.79	(6.66)	12.02	(8.49)	23.18
CRSP	2.85	0.66	0.22	0.56	2.83	(3.38)	7.09	(4.35)	16.14
VERV	5.61	2.50	0.50	(1.79)	3.28	(7.73)	9.83	(5.64)	83.78
BEAM	2.87	0.18	0.05	0.24	4.23	(2.92)	6.28	(4.15)	26.62
PRME	6.84	1.82	0.30	1.04	5.67	(9.04)	21.58	(10.81)	41.91
SANA	4.85	1.42	0.36	1.02	3.47	(6.48)	12.50	(7.06)	31.62

Climb Bio Corporate Management

Chandra JD	VP Counsel	Profile
Jo PalmerPhillips	Chief Officer	Profile
Emily CPA	Senior Officer	Profile
Cindy MBA	Senior Finance	Profile
Emily Pimblett	Chief Officer	Profile
Nishi MD	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC